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1. Introduction
  Liver play an important role in regulation of physiological 
processes mainly for carbohydrate, protein and fat 
metabolism, secretion of bile, storage of vitamins 
and xenobiotics or drug detoxification. In other hand, 
xenobiotics or drug can damage the liver cells. Almost all 
of the hepatotoxic chemicals damage liver cells mainly 
by inducing lipid peroxidation and other oxidative liver 
damages in liver[1,2]. Currently there are not many available 
drugs for treatment of liver disorders, which makes a 
consideration to develop new drugs with less side effect. 
  Curcumin (diferuloylmethane), a yellow pigment present 
in the food flavour spice turmeric, has been shown to 
have a wide spectrum of biological actions[3,4]. Curcumin 
exerted hepatoprotective effects of liver injury in various 
animal models against toxic effects of agent such as 
carbon tetrachloride[5,6], endotoxin[7] and thioacetamide[8]. 
Our groups has been synthesized pentagamavunon-0 
(PGV-0), the derivatives of curcumin which has the 
biological activities higher than curcumin. PGV-0 has 
demonstrated the biological activities such as antioxidant, 
antiinflammatory and inhibit cyclooxygenase enzyme[9]. In 
addition, the derivatives did not significantly shown toxic 
effects on acute and subchronic toxicity testing. 
  Carbon tetrachloride (CCl4) proves highly useful as an 
experimental model for the study of certain hepatotoxic 
effects for screening the anti-hepatotoxic/hepatoprotective 
activity of drugs or new compound in experimental model, 
because the CCl4-induced hepatotoxicity is regarded and 
similar as and analogue of liver injury caused by variety 
of hepatotoxins in human[10,11] . It has been accepted that 
CCl4-induced heptotoxicity results from its hepatotoxic 
metabolite  and radical such  as trichloromethyl free radical 
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(
•
CCl3) and trichloromethylperoxy free radical (CCl3O2
•
). 
This free radicals can react with sulfhydryl groups, such 
as glutathione (GSH) and thiol-groups in the side chain of 
protein. Both trichloromethyl and its peroxy radical are also 
capable covalently binds to proteins or lipids, and then 
initiates the lipid peroxidation in the cellular membrane and 
liver damage, which eventually leads to the various liver 
pathological processes of diseases[11,12]. Therefore, one of the 
terapeutic strategy against hepatotoxicity and liver injury is 
to find the antioxidant compounds that are capable to protect 
liver injury through free radical scavenging generated by 
CCl4.
  There has been growing interest in the analysis of PGV-0 
conducted by intense research into their potential benefits 
to human health. One of their main activities in this regard 
is their antioxidant activity, which enables them to attenuate 
the development of tumor and inflammatory disease. PGV-0 
have the antioxidant activity more potent than curcumin[9]. 
Antioxidant plays an important role in inhibiting and 
scavenging free radicals, thus providing protection to 
humans against infection and degenerative diseases. 
According to the important role of that antioxidant activity 
of PGV-0, the present study was carried out to evaluate the 
antioxidant and hepatoprotective activity of PGV-0 against 
CCl4-induced liver damage in rats.
2. Materials and methods
2.1. Materials
  PGV-0 was obtained from Curcumin Research Center, 
Faculty of Pharmacy, Gadjah Mada University. CCl4, 
glutathione, and 5,5’-dithio bis-2-nitrobenzoic acid (DTNB), 
H2O2, sodium nitroprusside (SNP), sulphanilamide and 
N-naphthyletylenediamine dihydrochloride were purchased 
from E. Merck, Darmstadt, Germany. Serum glutamate 
pyruvate transaminase (SGPT), serum alkaline phosphatase 
(SALP), total bilirubin were analyzed using reagent kits 
(DiaSys Diagnostic, Holzheim, Germany). All other reagents 
were of analytical grade.
2.2. Animals
  Studies were carried out using male Wistar albino rats (180-
200 g). Rats were obtained from the animal house, Faculty of 
Pharmacy Gadjah Mada University, Yogyakarta, Indonesia. 
The animals were grouped and housed in polyacrylic cages 
(38 cm 伊 23 cm 伊 10 cm) with not more than five animals per 
cage and maintained under standard laboratory conditions 
[temperature (25依3) 曟] with dark and light cycle (12/12 h)
and allowed free access to standard pellet diet and reverse 
osmosis water ad libitum. Rats were acclimatized to 
laboratory condition for 1 week before commencement of 
experiment. All procedures and protocol described were 
conducted in accordance with Guideline for Care and Use of 
Laboratory Animals of Institutional Animal Ethics Commitee 
of Gadjah Mada University.
2.3. Hepatoprotective study
  Thirty five healthy Wistar albino rats were divided into 
7 groups each containing 5 animals. Group 1 (normal) 
administered with vehicle (CMC Na 0.5%, p.o.) for 6 days. 
Group 2 (PGV-0 only) administered with PGV-0, 20 mg/kg, 
p.o. for six days. Group 3 (hepatotoxic group) administered 
with vehicle (CMC Na 0.5 %, p.o.) for six days and on day 7 
treated with CCl4, 2.0 mL/kg, i.p. Groups 4-7 administered 
with PGV-0 at a dose of 2.5, 5, 10, and 20 mg/kg, p.o., 
respectively for six days and on day 7 treated with CCl4,
2.0 mL/kg, i.p. After 48 hours of CCl4 administration, the blood 
was collected through retro-orbital plexus for determination 
of SGPT, ALP and total bilirubin. Finally, animals were 
sacrificed and liver quickly removed and excised, rinsed 
in ice cold normal saline followed by 0.15 M Tris-HCl (pH 
7.4) blotted dry and weighed. A 10 % w/v of homogenate was 
prepared in 0.15 M Tris-HCl buffer. A part of homogenate 
after precipitating proteins with trichloroacetic acid (TCA) 
was used for estimation of glutathione by the method of 
Ellman[13]. The rest of the homogenate was centrifuged at
15 000 rpm for 15 min at 4 曟. The supernatant thus obtained 
was used for the estimation of catalase (CAT) activities was 
measured by the method of Aebi[14].
2.4. Estimation of glutathione (GSH) 
  The procedure to estimate the reduced GSH level 
followed to the method as described by Ellman [13]. The 
homogenate (in 0.1 M  phosphate buffer, pH 7.4) was 
added with equal volume of 20% TCA containing 1 mM 
EDTA to precipitate the tissue proteins. The mixture 
was allowed to stand for 5 min prior to centrifugation for 
10 min at 200 rpm. The supernatant (200 毺L) was then
transferred to a new set of test tubes and added 1.8 mL of 
the Ellman’s reagent (DTNB, 0.1 mM) was prepared in 0.3 
M phosphate buffer with 1% of sodium citrate solution). 
Then all the test tubes make upto the volume of 2 mL. After 
completion of the total reaction, solutions were measured at 
412 nm against blank. Absorbance values were compared 
with a standard curve generated from standard curve from 
known GSH. The glutathione level in liver was calculated as 
micromoL/g liver.
2.5. Estimation of CAT
  CAT ac t iv i ty  was  measured by  the  method o f
Aebi[14]. Supernatant (0.1 mL) was added to cuvette 
containing 1.9 mL of 50 mM phosphate buffer (pH 7.0). 
Reaction was started by the addition of 1.0 mL of freshly 
prepared 30 mM H2O2. The rate of decomposition of H2O2 
was measured spectrophotometrically from changes in 
absorbance at 240 nm. Activity of catalase was expressed as 
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specific activity as unit/mg protein or total activity as unit.
mg liver.
2.6. Assay of NO radical scavenging activity
  Various concentrations of PGV-0 and SNP (10 mM, final 
concentration) in phosphate buffered saline in a final 
volume of 2 mL were incubated at 25 曟 for 150 min. A 
control experiment without tested compounds but with the 
equivalent amount of vehicles was conducted in an identical 
manner of control. After incubation, 1.0 mL samples of 
reaction mixtures containing nitrite were removed and 
diluted with 1.0 mL of Griess reagent (1% sulphanilamide 
and 0.1% N-naphthyletylenediamine dihydrochloride in 2% 
H3PO4 ). The absorbance of these solutions were measured 
at 540 nm against the corresponding blank solutions. The 
effective scavenging (ES) value is the concentration of sample 
required to scavenge 50% of the NO radicals. Addition of 
varied concentrations of PGV-0 into the reaction mixture 
affected an increase in total absorbance upon treatment 
with Griess reagent. It indicated that the PGV-0 interfered 
with the absorbance value of nitrite detection. Therefore, in 
these experiments we had to exclude this interference by 
subtracting their absorbance at each concentration.
2.7. Statistical analysis
  The data are presented as the mean依SEM. The statistical 
significance of differences between the groups were 
assessed with a one-way ANOVA, followed by Bonferroni 
post-hoc test analysis using rel 13.0 software SPSS (Chicago, 
IL, USA). * P<0.05; ** P<0.01; and *** P<0.001 considered 
statistically significant.
3. Results
3.1. Effect of PGV-0 on SGPT, ALP and total bilirubin
 
  The result demonstrtated in Table 1 showed the effect 
of PGV-0 on SGPT, ALP and total bilirubin.  The result 
demonstrated that SGPT, SALP and total bilirubin were 
found to be significantly increased in rats treated with 
CCl4 when compared with the normal group (P<0.001). The 
administration of PGV-0 for 6 days significantly decreased 
the activity of serum transaminase in a dose-dependent 
manner, SALP and total bilirubin in CCl4-induced liver 
damage in rats compared to that of hepatotoxic group (CCl4 
treatment) (P<0.01, P<0.001).  
3.2. GSH level in liver tissues 
  The result in Table 2 showed the effect of PGV-0 on 
glutathione content in the liver. The content of GSH 
level in liver in hepatotoxic group (CCl4 treatment) was 
significantly depleted compared to normal group (P<0.001). 
The administration of PGV-0 at doses 2.5-20 mg/kg was 
significant dose-dependent to restore the GSH content of 
Table 1
Effect of administration of PGV-0 on serum GPT level, ALP and total bilirubin against CCl4-induced liver damage in rats.
Treatment/group
SGPT (IU/L) ALP (IU/L) Total bilirubin (mg/dL)
Pre-treatment Post- treatment Pre-treatment Post- treatment Pre-treatment Post-treatment
Normal(CMC Na, 0.5%) 64.20依3.04   62.80依2.08 331.40依14.44    337.20依22.16 0.388依0.013 0.372依0.014
PGV-0 only(20 mg/kg) 57.40依2.98   95.40依6.68 479.40依31.39    637.40依30.88 0.290依0.010 0.400依0.017
Hepatotoxic(CCl4, 2.0 mL/kg) 69.20依1.07 982.00依57.10
### 330.80依18.90 1 627.20依43.75### 0.406依0.016 0.612依0.030###
PGV-0(2.5 mg/kg) + CCl4 71.40依2.87 906.00依29.30 612.40依15.76 1 127.60依68.43
** 0.388依0.016 0.552依0.043
PGV-0(5 mg/kg) + CCl4 74.75依3.53 803.60依56.39 446.00依23.76 1 091.60依93.23
** 0.314依0.022 0.584依0.017
PGV-0(10 mg/kg) + CCl4 61.50依1.55 581.50依65.43
*** 523.00依42.04   791.50依59.39*** 0.330依0.017 0.480依0.018*
PGV-0(20 mg/kg) + CCl4 65.00依2.19 203.20依9.82
*** 316.80依29.69   510.40依14.60*** 0.392依0.015 0.322依0.016***
Data were expressed as mean依SEM. ### P<0.001 significantly different to normal group.  * P<0.05; ** P<0.01; and *** P <0.001 significantly 
different to hepatotoxic group (CCl4 treatment).
Table 2
Effect of administration of PGV-0 on catalase and glutathione content against CCl4-induced liver damage in rats.
Treatment/group
CAT
Glutathione content(毺mol/g liver)Specific activity (unit/mg protein) Total activity (unit. mg liver)
Normal (CMC Na, 0.5%) 18.72依0.97   63.80依3.35 1.99依0.11
PGV-0 only (20 mg/kg) 22.52依0.98 113.29依4.63 2.23依0.08
Hepatotoxic (CCl4, 2.0 mL/kg)       5.72依0.51
###      23.06依1.16###     0.76依0.11###
PGV-0 (2.5 mg/kg ) + CCl4   6.09依0.77  35.84依3.59    1.40依0.07
**
PGV-0 (5 mg/kg ) + CCl4    9.21依0.10
*     55.60依0.58***    1.38依0.14**
PGV-0 (10 mg/kg ) + CCl4   10.67依0.39
**     68.19依2.68***     1.85依0.05***
PGV-0 (20 mg/kg ) + CCl4    14.65依0.77
***     88.63依4.51***     1.89依0.10***
Data were expressed as mean依SEM. ### P<0.001 significantly different to normal group.  * P<0.05; ** P<0.01; and *** P <0.001 significantly 
different to hepatotoxic group (CCl4 treatment).
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liver (P<0.01, P<0.001) against CCl4-induced GSH depletion. 
PGV-0 (10 and 20 mg/kg) administration for 6 days was 
able to reverse of GSH to normal level (P<0.001). Therefore, 
PGV-0 is capable to protect the depletion of GSH content 
against CCl4-induced liver damaged. 
3.3. Catalase activity in liver tissues 
  The result demonstrated that CAT activity in liver of CCl4 
treatment group was significantly lower than normal group 
(Table 2) (P<0.001). The administration of PGV-0 significant 
dose-dependent increased CAT activity compared to CCl4 
treatment group (specific activity, P<0.01, P<0.001 and total 
activity, P<0.001). The administration PGV-0, 10 and 20 mg/kg
completely restored the CAT activity to the normal level. The 
results suggest that PGV-0 capable to protect the reduction 
of CAT against CCl4-induced liver damaged.
3.4. In vitro NO free radical scavenging activity 
  The effect of PGV-0 on NO free radical scavenging activity 
is presented in Table 3. In order to know the mechanisms 
of hepatoprotective of PGV-0, it is necessary to investigate 
the antioxidant effect of PGV-0. The result demonstrated 
the dose-dependent radical scavenging activity of NO free 
radical upon decomposition of sodium nitroprusside. The 
result suggest that PGV-0 is capable to scavenge NO free 
radical (ES50=32.34 毺M). 
Table 3
The effects of PGV-0 on the accumulation of nitrite upon 
decomposition of sodium nitroprusside (10 mM). 
Group/treatment % Free radical scavenger
Control (DMSO)          -
PGV-0, 5 毺M   3.23依4.08
PGV-0, 10 毺M 11.73依 0.47
PGV-0, 20 毺M 40.08依3.20
PGV-0, 30 毺M 46.51依1.13
PGV-0, 40 毺M 60.91依1.95
Data were expressed as mean依SEM (n=5). 
4. Discussion
  In the assessment of liver damage by hepatotoxin, CCl4 is 
one of the most commonly used in the experimental study 
of liver diseases[10,11]. The administration of CCl4 induced 
hepatotoxic undergoes enzymatic activation, majorly by 
CYP2E1, into membrane of endoplasmic reticulum. These 
processes are followed by chlorometylation and lipid 
peroxidation of endoplasmic reticulum membrane[11,12]. The 
elevated levels of serum enzymes such as SGPT and SGOT 
are indicative of cellular leakages and loss of functional 
integrity of membrane cell of liver. The membrane damage or 
necrosis releases the enzyme from the liver into circulation. 
The serum level of SGPT and SGOT are largely used for 
determination of liver damage. However, the level of SGPT is 
more specific to the liver, and is thus a better parameter for 
detecting liver injury[15]. Administration of CCl4 significantly 
raises the serum levels of SGPT. The results demontrated 
that PGV-0 at doses 10 and 20 mg/kg significantly decreased 
the activity of SGPT levels, which may be a consequence 
of the protection of membrane cell from trichloromethyl 
free radical and trichloromethylperoxy free radical as well 
as repair of the liver tissue damage caused by CCl4. In the 
other hand, activity of serum ALP and bilirubin also related 
to the function of hepatic cell. Our results using CCl4-
induced hepatotoxicity model in rats demonstrated that 
PGV-0 significantly decrease the activity of serum ALP and 
total bilirubin levels at the dose-dependent manner. The 
stabilization of SGPT, ALP and total bilirubin level by PGV-0 
is an indicator of the improvement of the functional status of 
the liver. This findings were supported by our previous result 
that HGV-1, an analogue curcumin also demonstrated the 
hepatoprotective effect against CCl4-induced liver injury[16].
GSH is an intracellular reductant and plays major role in 
catalysis, metabolism and transport. GSH plays a protective 
role in tissue by detoxification of xenobiotics and essential 
to maintain structural and functions integrity of the cell. It 
protects cells against free radicals, peroxides and other toxic 
compounds. GSH is a naturally occurring substance that 
is abundant in many living cells. It is widely known that a 
deficiency of GSH within living organisms can lead to tissue 
disorder and injury[17]. In the present study, administration 
of hepatotoxin CCl4 significantly induced the depletion 
of GSH in the liver and caused imbalance of GSH/GSSH. 
Interaction of the reduced form of GSH with free radical 
readily converted to oxidized form GSSH. The present study 
showed the administration of PGV-0 prevent depletion of 
GSH in CCl4-treated rats.  The administration of PGV-0 
during severe liver damage condition has elevated the GSH 
levels, which in turn helps in maintaining the liver tissue 
damage. This results indicates the additional antioxidant 
property of PGV-0. The results are consistent with the 
previous studies that some hepatoprotective compounds 
has a capability of enhancing GSH level to preserve GSH 
level[18,19]. 
  CAT is a one of the key component of the antioxidant 
defense system. CAT decomposes hydrogen peroxide and 
protects the tissue from highly reactive hydroxyl radical. 
Therefore, the reduction of these protective mechanisms 
results in enhanced sensitivity to free radical-induced 
cellular damage. The accumulation of some free radical may 
results in a number of deleterious effects and alterations 
in the biological activity of cellular macromolecules. 
Administration of PGV-0 increases the activities of 
catalase in CCl4-induced liver damage rats to prevent the 
accumulation of free radicals and protects the CCl4-induced 
liver damage. 
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  Several lines of evidences reported that curcumin is 
exhibit a strong antioxidant activity. It is a potent scavenger 
of a variety of ROS including superoxide anion radicals, 
hydroxyl radicals and nitrogen dioxide radicals[3,20]. PGV-0 
is one of curcumin analogue that may have a similar action 
as hepatoprotective. In order to clarify the mode of action 
of PGV-0, the in vitro NO radical scavenger was carried 
out. The compound that possesses NO scavenging activity 
inhibited nitrite formation by competing with oxygen to react 
with NO. This lead to the reduction of nitrite concentration 
in the medium assay. PGV-0 effectively reduced the 
generation of NO radicals and scavenged NO radicals in a 
dose dependent manner. PGV-0 exhibited strong NO radical 
scavenging with low ES50 values (32.34 毺M). Sardjiman[9] 
reported that change 毬-diketo to cyclopentanones having 
a C5 linker and the 4-hydroxyphenyl group confers potent 
antioxidant activity, which is much enhanced by one, or two, 
methoxy susbstituents ortho to the hydroxy group such like 
PGV-0. Therefore, PGV-0 may act as hepatoprotective in 
CCl4-treated by scavenger free radical and reactive oxygen 
species formed during CCl4 metabolism.
  In conclusion, the results of the present study demonstrate 
that PGV-0 up to 20 mg/kg has a potent hepatoprotective 
action upon carbon tetrachloride-induced hepatic damage 
in rats. Our results show that the hepatoprotective effects 
of PGV-0 may be due to its antioxidant and free radical 
scavenging properties. 
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